Proteome Sciences plc
OTC: PMSNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Jon Faber
- Employees
- 36
- Headquarters
- Cobham, United Kingdom
- IPO year
- 2010
- Market cap
- $5.8M
- Website
- https://www.proteomics.com
Loading PMSNF…
Loading profile data…Frequently asked questions about PMSNF
What does Proteome Sciences plc (PMSNF) do?
Proteome Sciences Plc is a provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. Th...
Where does PMSNF trade?
Proteome Sciences plc (PMSNF) trades on the Other OTC.
What sector is PMSNF in?
Proteome Sciences plc (PMSNF) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Proteome Sciences plc?
Jon Faber is the chief executive officer of Proteome Sciences plc (PMSNF).
Where is Proteome Sciences plc headquartered?
Proteome Sciences plc is headquartered in United Kingdom.
Does PMSNF pay a dividend?
Proteome Sciences plc (PMSNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PMSNF go public?
Proteome Sciences plc (PMSNF) completed its initial public offering in 2010.